Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Ex-dividend declines

Wed, 17th Nov 2010 13:38

Footsie's fallers are dominated by shares that are going ex-dividend.Marks & Spencer, Carnival, Sainsbury and Vodafone have all gone ex-dividend today. Retailer Marks & Spencer is paying an interim dividend of 6.2p a share but the share price has fallen by nearly double the amount of the dividend. Cruise company Carnival's final dividend is 10 cents a share - equivalent to 6.3p a share. That does not explain a decline in the share price of more than six times the dividend payment. Supermarkets group Sainsbury has fallen more than its 4.3p a share interim dividend but by a more modest 2p a share. Mobile phone networks operator Vodafone is paying an interim dividend of 2.85p a share, which is similar to the size of the fall in the share price. Credit checking firm Experian is experiencing improving trends across all regions in the first half of its financial year. Revenue from continuing activities in the six months to September 2010 was up 8% at constant exchange rates, while organic revenue growth was 7%. Total group revenue improved to $2bn from $1.9bn the year before. Profit before tax fell to $283m from $316m.Derivatives broker ICAP reported first half underlying revenue that is 2% ahead of last time. Total turnover in the half year to September 201 rose by 9% to £867m, but profits tumbled from £150m to £116m after one-off charges. Underlying profits rose by 2% to £183m.Panmure Gordon has upgraded its forecasts for GlaxoSmithKline following the endorsement of potential Lupus drug Benlysta by an FDA advisory committee by a margin of 13-2. The broker has upgraded 2013 earnings by 1.6% and 2014 earnings by 1.5%. FTSE 100 - RisersExperian (EXPN) 755.50p +7.39%GlaxoSmithKline (GSK) 1,238.00p +2.02%ICAP (IAP) 473.80p +1.70%SABMiller (SAB) 2,040.00p +1.27%Old Mutual (OML) 128.00p +1.27%Autonomy Corporation (AU.) 1,414.00p +1.14%Standard Life (SL.) 222.30p +1.00%ARM Holdings (ARM) 355.50p +0.91%Royal Bank of Scotland Group (RBS) 41.19p +0.81%Reed Elsevier (REL) 534.00p +0.75%FTSE 100 - FallersMarks & Spencer Group (MKS) 383.90p -3.06%Fresnillo (FRES) 1,329.00p -2.35%Man Group (EMG) 274.90p -2.14%African Barrick Gold (ABG) 539.50p -2.09%Vodafone Group (VOD) 167.00p -2.02%Sainsbury (J) (SBRY) 366.60p -1.90%3i Group (III) 309.00p -1.87%Carnival (CCL) 2,588.00p -1.63%Cobham (COB) 201.20p -1.61%Eurasian Natural Resources Corp. (ENRC) 905.00p -1.58%
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.